10mg
Want to read up on others' experiences with this compound? Join our Facebook group and engage directly with thousands of others who use this product!
Alternatively, follow our Facebook page for the latest updates and product announcements!
CAGRISEMA
CagriSema is a new investigational medicine developed by Novo Nordisk that combines Cagrilintide and Semaglutide. CagriSema is not yet being prescribed by doctors. Participant will get injections once a week throughout the treatment period
$159.99
Before Placing Your Order:
Please read our FAQ to understand more about the ordering process.
